Encodia
Latest round
- Series C
Last raised
- Jan 2021
Total raised
- $76M
Investors
- 9
About Encodia
Encodia, Inc. is a biotechnology company specializing in advanced protein sequencing technologies that enhance understanding of cellular processes for personalized medicine.Founded in 2015 in San Diego, US, Encodia, Inc. specializes in protein sequencing using proprietary technologies. The company was established by Kevin Gunderson and Michael Weiner.Encodia’s core product offering centers around its proprietary ProteoCode™ technology, which enables large-scale protein sequencing through a novel approach known as reverse-translation. This technology is designed to enhance the understanding of cellular processes, facilitating advancements in personalized medicine. By utilizing next-generation sequencing (NGS) techniques and amino acid barcoded libraries, Encodia’s solutions integrate seamlessly with multiomic approaches to provide comprehensive data analysis.Encodia's revenue model is primarily based on B2B transactions, involving partnerships and collaborations with research institutions and biotechnology companies. The company engages in agreements where clients access its ProteoCode™ technology and related services, typically structured around multi-year contracts or project-based collaborations. These arrangements often involve tiered pricing based on project scale and complexity, ensuring that clients receive tailored solutions that meet their specific needs.Moving forward, Encodia plans to design new products leveraging its ProteoCode™ technology with anticipated releases aimed at expanding its market reach, particularly into new geographic regions. The company aims to enhance its presence in Europe and Asia by 2023.78 mn will be utilized to support these new product developments and facilitate market entry strategies in the targeted regions, strengthening its commitment to advancing biotechnological applications.
Who invested in Encodia
9 investors across 1 round
See all investors in Encodia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jan 27, 2021
Amount
$76M
Investors
Questions about Encodia
Who invested in Encodia?
Encodia has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Encodia raised?
Encodia has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Encodia last raise money?
Encodia's most recent round on record is a Series C, in Jan 2021.
What does Encodia do?
Encodia is a biotechnology company.
Where is Encodia headquartered?
Encodia is headquartered in San Diego, US.
Which VCs invest in companies like Encodia?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Encodia's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Encodia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.